EMUCTV: Real world vs clinical trial outcomes in ccRCC patients eligible for adjuvant Pembrolizumab
Posted on November 7, 2026 in News
Assoc. Prof. Carlotta Palumbo (IT) alongside Dr. Luca Lambertini (IT) discuss Dr. Lambertini’s study: Real world vs clinical trial outcomes in ccRCC patients eligible for adjuvant Pembrolizumab.
